Eplerenone for Chronic Central Serous Chorioretinopathy – (VICI): a Randomised, Double-blind, Placebo-Controlled Trial
Christian J. Sanfilippo, MD  |  February 23, 2021
Continue Reading
Outcomes of Combined Phacoemulsification and Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment: A Comparative Study
Jaya B. Kumar, MD  |  February 11, 2021
Continue Reading
Endophthalmitis after Cataract Surgery: Changes in Management Based on Microbiologic Cultures
Philip P. Storey, MD  |  February 2, 2021
Continue Reading
Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study
Wenlan (Wendy) Zhang, MD  |  January 24, 2021
Continue Reading
Factors Associated With the Use of 360-Degree Laser Retinopexy During Primary Vitrectomy With or Without Scleral Buckle for Rhegmatogenous Retinal Detachment and Impact on Surgical Outcomes
Andrew Tye, MD  |  January 16, 2021
Continue Reading
Frequency of Rhegmatogenous Retinal Detachment after Intravitreal Therapy in Neovascular Age-Related Macular Degeneration
Priya Sharma Vakharia, MD  |  January 7, 2021
Continue Reading
Aqueous Chlorhexidine Compared to Povidone Iodine as Ocular Antisepsis Prior to Intravitreal Injection: A Randomized Clinical Trial
Daniel Su, MD  |  December 30, 2020
Continue Reading
Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT
Mohsin H. Ali, MD  |  December 19, 2020
Continue Reading
Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry
Rehan M. Hussain, MD  |  December 8, 2020
Continue Reading
Randomized Safety and Feasibility Trial of Ultra-Rapid Cooling Anesthesia for Intravitreal Injections
Akshay S. Thomas, MD  |  November 30, 2020
Continue Reading
Paracentral and Cecocentral Scotomas after Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment
Vlad Matei, MD  |  November 16, 2020
Continue Reading
Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice
Joshua D. Levinson, MD  |  November 10, 2020
Continue Reading